The Top Cannabis Stock Every Investor Should Be Buying Today

Here’s why Curaleaf Holdings (TSXV:CURA) is my top pick for cannabis investors looking to take advantage of potential U.S. legalization.

| More on:
edit Jars of marijuana

Image source: Getty Images

The hype is real in the cannabis sector today. Investors are growing increasingly bullish on the potential for cannabis companies to take advantage of U.S. Federal legalization. Indeed, a Biden White House and Democrat Senate all but seem to guarantee this catalyst.

Accordingly, for investors who are looking to play the cannabis space, Curaleaf (TSXV:CURA) is the hands-down best pick. Here’s why.

Curaleaf is in an enviable position relative to its peers 

Recently, the executive chairman of Curaleaf, Boris Jordan, said that the federal legalization of cannabis might not take place until the second half of Joe Biden’s term. However, the largest cannabis company in the U.S. is still in a great position to make the most of this catalyst, even if investors have to wait.

Curaleaf has a sustainable, vertically integrated business model. This is precisely what makes Curaleaf so interesting to me. The company cultivates, processes, markets, and sells its products. Today, it operates in 23 states with 101 dispensaries, 30 processing sites and more than 23 cultivation sites. Indeed, this company has a significant head start in the U.S. cannabis market compared to its Canadian peers.

Curaleaf’s earnings reports convey the fact that this company is in a strong financial position. The company produced s a 205% year-over-year increase in its revenue. Once the company’s deal to acquire Grassroots closes, its growth rate could accelerate. Furthermore, Curaleaf’s margin has increased to 48%, indicating that the company has been growing profitably.

These fundamentals, combined with the company’s dominant U.S. position, makes it a stand-out in the cannabis sector today.

New European acquisition will strengthen global presence

Curaleaf is set to strengthen its global presence by acquiring Emmac Life Sciences, a European cannabis company, for US$286 million. By completing the takeover, Curaleaf will enter eight new cannabis markets in Europe. These include Italy, Spain, and Germany. Indeed, this acquisition could position Curaleaf as the largest cannabis company in the world based on revenue and the extent of operations.

Yes, Europe only allows medical cannabis as of today. However, it appears that more countries are considering the legalization of recreational use. It is believed that Switzerland and the Netherlands are already set to launch recreational programs within 2021. Jordan revealed that Curaleaf plans to acquire more companies in Europe. By entering these markets, the company can eventually expand its operations to the Middle East and Africa.

Countries like South Africa and Poland are considering recreational legalization. Hence, more acquisitions in Europe can be instrumental in facilitating the future expansion of global operations.

Bottom line

Strong financials, a prudent business model, and an aggressive acquisition strategy are what sets this company apart from its peers. I have no doubts that this cannabis stock is the ideal option for growth investors who want to play this space. For those seeking cannabis exposure, this is my top pick today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »